In vivo analysis reveals new resonances at ~10.1, 11.3, and 11.7 ppm in skeletal muscle, suggesting unexplored metabolic roles.
Motivation: Most previous downfield ¹H MRS studies have focused on brain metabolites, with relatively few investigations conducted on skeletal muscle. Goal(s): To characterize the downfield metabolites in human skeletal muscle in vivo at 3T. Approach: An optimized metabolite-cycled (MC)-sLASER was used to simultaneously measure the metabolites in the upfield and downfield regions of the skeletal muscle ¹H spectra. Results: We detected three new peaks at ~10.1, 11.3, 11.7 ppm in the downfield region of the ¹H MRS of skeletal muscle at 3T that were not reported previously alongside the common upfield/downfield metabolites such as carnosine, IMCL/EMCL, creatine, TMA. Impact: This is the first reported detection of new resonances at ~10.1, 11.3, and 11.7ppm in downfield of the ¹H MRS of skeletal muscle at 3T. This will be beneficial to study role of these metabolites in healthy and disease condition.
No takes yet. Share an insight, caveat, or question.
Sarma et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: